Literature DB >> 8392291

Clinical, metabolic, and genetic aspects of cytochrome C oxidase deficiency in Saguenay-Lac-Saint-Jean.

C Morin1, G Mitchell, J Larochelle, M Lambert, H Ogier, B H Robinson, M De Braekeleer.   

Abstract

Thirty-four children with lactic acidosis and Leigh encephalopathy due to cytochrome C oxidase (COX) deficiency distributed in 28 families have recently been identified in northeastern Quebec, particularly in the Saguenay-Lac-Saint-Jean (SLSJ) region. The segregation analysis was consistent with an autosomal recessive mode of inheritance. The incidence was estimated at 1/2,063 live births between 1979 and 1990, and the carrier rate was estimated at 1/23 inhabitants in SLSJ. In SLSJ, the places of origin of the COX-deficient children and their parents did not show a clustered nonuniform distribution. The genealogical reconstruction of 54 obligate carriers identified 26 ancestors common to all of them. Twenty-two were 17th-century Europeans, suggesting that the COX-deficient gene was introduced in the French-Canadian population by early settlers. These results support the hypothesis of a founder effect for COX deficiency in northeastern Quebec. Clinical findings are reported for 15 of these COX-deficient patients, age 6 mo to 11 years. Moderate developmental delay, hypotonia, ataxia, strabismus, and mild facial dysmorphism were frequent. Eleven children died in episodes of fulminant metabolic acidosis. The patients had elevated blood and cerebrospinal fluid lactate levels, decreased blood bicarbonate levels, and normal blood pH. Leigh disease and microvesicular steatosis of the liver were present in all affected patients for whom postmortem examination was performed. This biochemically uniform group of patients showed a wide range of clinical severity.

Entities:  

Mesh:

Year:  1993        PMID: 8392291      PMCID: PMC1682365     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  Cytochrome c oxidase deficiency in Leigh syndrome.

Authors:  S DiMauro; S Servidei; M Zeviani; M DiRocco; D C DeVivo; S DiDonato; G Uziel; K Berry; G Hoganson; S D Johnsen
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

2.  Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue.

Authors:  J L Willems; L A Monnens; J M Trijbels; J H Veerkamp; A E Meyer; K van Dam; U van Haelst
Journal:  Pediatrics       Date:  1977-12       Impact factor: 7.124

3.  Cytochrome c oxidase deficiency.

Authors:  S DiMauro; M Zeviani; E Bonilla; N Bresolin; M Nakagawa; A F Miranda; M Moggio
Journal:  Biochem Soc Trans       Date:  1985-08       Impact factor: 5.407

4.  Clinical presentation of mitochondrial respiratory chain defects in NADH-coenzyme Q reductase and cytochrome oxidase: clues to pathogenesis of Leigh disease.

Authors:  B H Robinson; L De Meirleir; M Glerum; G Sherwood; L Becker
Journal:  J Pediatr       Date:  1987-02       Impact factor: 4.406

Review 5.  Leigh syndrome, a mitochondrial encephalo(myo)pathy. A review of the literature.

Authors:  P M van Erven; J P Cillessen; E M Eekhoff; F J Gabreëls; W H Doesburg; W A Lemmens; J L Slooff; W O Renier; W Ruitenbeek
Journal:  Clin Neurol Neurosurg       Date:  1987       Impact factor: 1.876

6.  Cytochrome C oxidase deficiency in two siblings with Leigh encephalomyelopathy.

Authors:  S Miyabayashi; K Narisawa; K Iinuma; K Tada; K Sakai; K Kobayashi; Y Kobayashi; S Morinaga
Journal:  Brain Dev       Date:  1984       Impact factor: 1.961

7.  A defective enzyme in hyperphenylalaninaemia due to biopterin deficiency.

Authors:  S Yoshioka; M Masada; T Yoshida; T Mizokami; M Akino; N Matsuo; T Tsuchiya; T Seki; S Arashima; M Kawaguchi
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

8.  Variable clinical presentation in patients with defective E1 component of pyruvate dehydrogenase complex.

Authors:  B H Robinson; H MacMillan; R Petrova-Benedict; W G Sherwood
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

9.  A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec.

Authors:  F Merante; R Petrova-Benedict; N MacKay; G Mitchell; M Lambert; C Morin; M De Braekeleer; R Laframboise; R Gagné; B H Robinson
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

10.  de Toni-Fanconi-Debré syndrome with Leigh syndrome revealing severe muscle cytochrome c oxidase deficiency.

Authors:  H Ogier; A Lombes; H R Scholte; B T Poll-The; M Fardeau; J Alcardi; B Vignes; P Niaudet; J M Saudubray
Journal:  J Pediatr       Date:  1988-05       Impact factor: 4.406

View more
  34 in total

1.  The role of the LRPPRC (leucine-rich pentatricopeptide repeat cassette) gene in cytochrome oxidase assembly: mutation causes lowered levels of COX (cytochrome c oxidase) I and COX III mRNA.

Authors:  Fenghao Xu; Charles Morin; Grant Mitchell; Cameron Ackerley; Brian H Robinson
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

2.  LRP130 protein remodels mitochondria and stimulates fatty acid oxidation.

Authors:  Lijun Liu; Masato Sanosaka; Shi Lei; Megan L Bestwick; Joseph H Frey; Yulia V Surovtseva; Gerald S Shadel; Marcus P Cooper
Journal:  J Biol Chem       Date:  2011-10-04       Impact factor: 5.157

3.  Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders.

Authors:  M P Vawter; H Tomita; F Meng; B Bolstad; J Li; S Evans; P Choudary; M Atz; L Shao; C Neal; D M Walsh; M Burmeister; T Speed; R Myers; E G Jones; S J Watson; H Akil; W E Bunney
Journal:  Mol Psychiatry       Date:  2006-04-25       Impact factor: 15.992

4.  Compulsory hyperventilation and hypocapnia of patients with Leigh syndrome associated with SURF1 gene mutations as a cause of low serum bicarbonates.

Authors:  E Pronicka; D H Piekutowska-Abramczuk; E Popowska; M Pronicki; E Karczmarewicz; Y Sykut-Cegielskâ; J Taybert
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

5.  A genomewide linkage-disequilibrium scan localizes the Saguenay-Lac-Saint-Jean cytochrome oxidase deficiency to 2p16.

Authors:  N Lee; M J Daly; T Delmonte; E S Lander; F Xu; T J Hudson; G A Mitchell; C C Morin; B H Robinson; J D Rioux
Journal:  Am J Hum Genet       Date:  2001-01-10       Impact factor: 11.025

Review 6.  Prevalence of ataxia in children: a systematic review.

Authors:  Kristin E Musselman; Cristina T Stoyanov; Rhul Marasigan; Mary E Jenkins; Jürgen Konczak; Susanne M Morton; Amy J Bastian
Journal:  Neurology       Date:  2013-11-27       Impact factor: 9.910

7.  Nutrient sensing by the mitochondrial transcription machinery dictates oxidative phosphorylation.

Authors:  Lijun Liu; Minwoo Nam; Wei Fan; Thomas E Akie; David C Hoaglin; Guangping Gao; John F Keaney; Marcus P Cooper
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

8.  A founder mutation in PET100 causes isolated complex IV deficiency in Lebanese individuals with Leigh syndrome.

Authors:  Sze Chern Lim; Katherine R Smith; David A Stroud; Alison G Compton; Elena J Tucker; Ayan Dasvarma; Luke C Gandolfo; Justine E Marum; Matthew McKenzie; Heidi L Peters; David Mowat; Peter G Procopis; Bridget Wilcken; John Christodoulou; Garry K Brown; Michael T Ryan; Melanie Bahlo; David R Thorburn
Journal:  Am J Hum Genet       Date:  2014-01-23       Impact factor: 11.025

9.  Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Authors:  P N Tonin; A M Mes-Masson; P A Futreal; K Morgan; M Mahon; W D Foulkes; D E Cole; D Provencher; P Ghadirian; S A Narod
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

10.  Leigh-Like Syndrome Due to Homoplasmic m.8993T>G Variant with Hypocitrullinemia and Unusual Biochemical Features Suggestive of Multiple Carboxylase Deficiency (MCD).

Authors:  Shanti Balasubramaniam; B Lewis; D M Mock; H M Said; M Tarailo-Graovac; A Mattman; C D van Karnebeek; D R Thorburn; R J Rodenburg; J Christodoulou
Journal:  JIMD Rep       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.